Przejdź do menu Przejdź do treści
Tłumacz języka migowego Migam
Zaloguj się
Tłumacz języka migowego Migam
Wybrane publikacje
Zespół prof. Claudine KIEDA

Wybrane publikacje

  • Grzymajlo K, El Hafny-Rahbi B, Kieda C. Tumour suppressor PTEN activity is differentially inducible by myo-inositol phosphates. J Cell Mol Med. 2023 Feb 27. doi: 10.1111/jcmm.17699.
  • Oknińska M, Mackiewicz U, Zajda K, Kieda C, Mączewski M. New potential treatment for cardiovascular disease through modulation of hemoglobin oxygen binding curve: Myo-inositol trispyrophosphate (ITPP), from cancer to cardiovascular disease. Biomed Pharmacother. 2022 Oct;154:113544. doi: 10.1016/j.biopha.2022.113544.
  • Thinard R, Farkas AE, Halasa M, Chevalier M, Brodaczewska K, Majewska A, Zdanowski R, Paprocka M, Rossowska J, Duc LT, Greferath R, Krizbai I, Van Leuven F, Kieda C, Nicolau C. „Endothelial Antibody Factory” at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases. Pharmaceutics. 2022 Jul 6;14(7):1418. doi: 10.3390/pharmaceutics14071418.
  • Maksym RB, Hoffmann-Młodzianowska M, Skibińska M, Rabijewski M, Mackiewicz A, Kieda C. Immunology and Immunotherapy of Endometriosis. J Clin Med. 2021 Dec 15;10(24):5879. doi: 10.3390/jcm10245879.
  • El Hafny-Rahbi B, Brodaczewska K, Collet G, Majewska A, Klimkiewicz K, Delalande A, Grillon C, Kieda C. Tumour angiogenesis normalized by myo-inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response. J Cell Mol Med. 2021 Apr;25(7):3284-3299. doi: 10.1111/jcmm.16399.
  • Oknińska M, Zambrowska Z, Zajda K, Paterek A, Brodaczewska K, Mackiewicz U, Szczylik C, Torbicki A, Kieda C, Mączewski M. Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate. Sci Rep. 2021 Sep 9;11(1):18002. doi: 10.1038/s41598-021-97470-6.
  • Oknińska M, El-Hafny-Rahbi B, Paterek A, Mackiewicz U, Crola-Da Silva C, Brodaczewska K, Mączewski M, Kieda C. Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells. J Cell Mol Med. 2020 Feb;24(3):2272-2283. doi: 10.1111/jcmm.14909.
  • Klimkiewicz K, Weglarczyk K, Collet G, Paprocka M, Guichard A, Sarna M, Jozkowicz A, Dulak J, Sarna T, Grillon C, Kieda C. A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection. Cancer Lett. 2017 Jun 28;396:10-20. doi: 10.1016/j.canlet.2017.03.006.
  • Collet G, Szade K, Nowak W, Klimkiewicz K, El Hafny-Rahbi B, Szczepanek K, Sugiyama D, Weglarczyk K, Foucault-Collet A, Guichard A, Mazan A, Nadim M, Fasani F, Lamerant-Fayel N, Grillon C, Petoud S, Beloeil JC, Jozkowicz A, Dulak J, Kieda C. Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia. Cancer Lett. 2016 Jan 28;370(2):345-57. doi: 10.1016/j.canlet.2015.11.008.
  • Kieda C, El Hafny-Rahbi B, Collet G, Lamerant-Fayel N, Grillon C, Guichard A, Dulak J, Jozkowicz A, Kotlinowski J, Fylaktakidou KC, Vidal A, Auzeloux P, Miot-Noirault E, Beloeil JC, Lehn JM, Nicolau C. Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment. J Mol Med (Berl). 2013 Jul;91(7):883-99. doi: 10.1007/s00109-013-0992-6.

Dr Halina WAŚ

Oryginalne:

  • Borkowska A.#, Olszewska A.#, Skarżyńska W., Marciniak M., Kieda C., and Was H. High hemin concentration induces escaping from senescence of normoxic and hypoxic colon cancer cells. Cancers 2022, 14(19), 4793; https://doi.org/10.3390/cancers14194793 (IF=6,575)
  • Kusienicka A., Bukowska-Strakova K., Cieśla M., Norbert Nowak W., Bronisz-Budzyńska I., Seretny A., Żukowska M., Jeż M., Krutyhołowa R., Taha H., Trojanowska-Kachamakova N., Was H., Kieda C., Józkowicz A. Heme oxygenase-1 has a greater effect on melanoma clonogenic and tumorigenic potential than the expression of melanoma initiating cell markers. Int J Mol Sci. 2022 Mar 25;23(7):3596. doi: 10.3390/ijms23073596 (IF=5,923)
  • Olszewska A., Borkowska A., Granica M., Karolczak J., Zglinicki B., Kieda C., and Was H. Escape from cisplatin-induced senescence of hypoxic lung cancer cells can be overcome by hydroxychloroquine. Front Oncol, 21 January 2022. doi.org/10.3389/fonc.2021.738385. (IF=5,738)
  • Piasecki P, Majewska A, Narloch J, Maciak M, Brodaczewska K, Kuc M, Was H, Wierzbicki M, Brzozowski K, Ziecina P, Mazurek A, Dziuk M, Iller E, Kieda C. A new in vitro model applied 90Y microspheres to study the effects of low dose beta radiation on colorectal cancer cell line in various oxygenation conditions. Sci Rep. 2021 Feb 24;11(1):4472. doi: 10.1038/s41598-021-84000-7 (IF=4,379)
  • Was H, Cichon T, Smolarczyk R, Lackowska B, Mazur-Bialy A, Mazur M, Szade A, Dominik P, Mazan M, Kotlinowski J, Zebzda A, Kusienicka A, Kieda C, Dulak J, Jozkowicz A. Effect of Heme Oxygenase-1 on Melanoma Development in Mice-Role of Tumor-Infiltrating Immune Cells. Antioxidants (Basel). 2020 Dec 3;9(12):1223. doi: 10.3390/antiox9121223. (IF=6,313)

 

Przeglądowe:

  • Was H., Borkowska A., Bagues A., Ty L., Liu JYH., Lu Z., Rudd JA., Nurgali K., Abalo R. Mechanism of chemotherapy-induced neurotoxicity. Front Pharmacol. 2022 Mar 28;13:750507. doi: 10.3389/fphar.2022.750507 (IF=5,988)
  • Was H., Borkowska A, Olszewska A, Klemba A, Marciniak M, Synowiec A, Kieda C. Polyploidy formation in cancer cells: How a Trojan horse is born. Semin Cancer Biol. 2021 Mar 13:S1044-579X(21)00053-5. doi: 10.1016/j.semcancer.2021.03.003 (IF=15,707)
  • Klemba A, Bodnar L, Was H, Brodaczewska KK, Wcislo G, Szczylik CA, Kieda C. Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies. Int J Mol Sci. 2020 Dec 14;21(24):9492. doi: 10.3390/ijms21249492 (IF=5,923)

 

Rozdziały w książkach:

  • Olszewska A.#, Granica M.#, Klemba A., Kieda C. and Was H. Role of cellular senescence in resistance to platinum-based chemotherapy. Platinum-Based Chemotherapy: Clinical Uses, Efficacy and Side Effects, Nova Science Publisher, 2022 Oct 20. doi.org/10.52305/MPSL2859.

Inne:

  • Nurgali K., Rudd J.A., Was H., Abalo R. Editorial: Cancer Therapy: The Challenge of Handling a Double-Edged Sword. Front Pharmacol. doi:10.3389/fphar.2022.1007762 (IF=5,998).